Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Share Price: 705.00p Change Today:  0.000p  Market Cap: 2,719.47m

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

1 Day Chart

6 Month Chart

BTG Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-13 233.70 24.10 14.50p 24.6 0.9 +27% n/a 0.0%
31-Mar-14 290.50 33.30 14.50p 37.4 n/a n/a n/a 0.0%
31-Mar-15 367.80 26.70 15.70p 45.5 5.7 +8% n/a 0.0%
31-Mar-16 447.50 57.50 21.90p 28.4 0.7 +40% n/a 0.0%
31-Mar-17 570.50 31.60 23.10p 25.4 4.2 +6% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BTG Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 596.42 138.99 29.46p 23.9 0.9 +28% n/a 0.0%
31-Mar-19 635.70 165.07 33.97p 20.8 1.4 +15% n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

BTG Company Announcements

Holding(s) in Company 23-Jun-2017 15:11 RNS
Holding(s) in Company 21-Jun-2017 10:01 RNS
Price Monitoring Extension 16-Jun-2017 16:35 RNS

Latest BTG Director Deals

Traded Action Notifier PriceAmountValue
09-Jun-17 Sell Dame Pamela Louise Makin 649.00p 30,641 198,860.08
09-Jun-17 Sell Rolf Soderstrom 649.00p 22,624 146,829.75
09-Jun-17 Transfer From Rolf Soderstrom 0.000p 42,624 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 705.00p
Change Today 0.000p
% Change 0.00 %
Volume 0
23-Jun-17 Close 705.00p
Shares Issued 385.74m
Market Cap 2,719.47m
Year End 31-Mar-17

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 9
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BTG Dividends

No dividends found

Trades for --2017

Time Volume / Share Price
0 @ 0.000p

BTG Key Personnel

CEO Dame Pamela Louise Makin
CFO Rolf Soderstrom
Chair Garry Watts